世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のポリデオキシリボヌデオチド(PDRN)市場調査レポート 2023年


Global Polydeoxyribonudeotide (PDRN) Market Research Report 2023

ポリデオキシリボヌデオチド(PDRN)の世界市場規模は2022年に2,582万米ドルで、2029年には2億8,632万米ドルに達すると予測され、予測期間2023-2029年のCAGRは43.39%である。市場規模の推定にあたっては、COVID-1... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年6月19日 US$2,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ポリデオキシリボヌデオチド(PDRN)の世界市場規模は2022年に2,582万米ドルで、2029年には2億8,632万米ドルに達すると予測され、予測期間2023-2029年のCAGRは43.39%である。市場規模の推定にあたっては、COVID-19とロシア・ウクライナ戦争の影響を考慮した。
ポリデオキシリボヌデオチド(PDRN)のヨーロッパ市場は、2023年の808万ドルから、2023年から2029年の予測期間中に41.26%のCAGRで、2029年までに6419万ドルに達すると推定される。
ポリデオキシリボヌデオチド(PDRN)の中国市場は、2023年に1,343万ドルから増加し、2023年から2029年の予測期間中に46.42%のCAGRで、2029年までに1億3,232万ドルに達すると推定される。
ポリデオキシリボヌデオチド(PDRN)の韓国市場は、2023年に1093万ドルから増加し、2023年から2029年の予測期間中に40.55%のCAGRで、2029年までに8426万ドルに達すると推定される。
ポリデオキシリボヌデオチド(PDRN)の世界の主要メーカーには、HTL Biotechnology、Ruijiming Biological、PharmaResearch Co.Ltd.、Humedix、ReaLi Tide Biological、HENGYU BIOPH、Mastelli、Dongkook、BR PHARM、BMI KOREA、BNF Solutionなどがあります。2022年には、世界のトップ3ベンダーが売上高の約55.53%を占めた。

レポートの範囲
本レポートは、ポリデオキシリボヌデオチド(PDRN)の世界市場を定量的・定性的分析の両面から包括的に紹介し、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ポリデオキシリボヌデオチド(PDRN)に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。

ポリデオキシリボヌデオチド(PDRN)の市場規模、推計、予測は、2022年を基準年として、生産量/出荷量(Kg)と収益(百万ドル)で提供し、2018年から2029年までの期間の履歴データと予測データを掲載しています。本レポートでは、世界のポリデオキシリボヌデオチド(PDRN)市場を包括的に区分しています。タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。
市場のより詳細な理解のために、競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。

本レポートは、ポリデオキシリボヌデオチド(PDRN)メーカー、新規参入企業、本市場における産業チェーン関連企業に対し、市場全体と、企業別、タイプ別、用途別、地域別といった異なるセグメントにわたるサブセグメントの収益、生産量、平均価格に関する情報を提供します。

企業別
HTLバイオテクノロジー
瑞金生物
ファルマリサーチ社
ヒューメディックス
麗麗潮生物製薬
HENGYU BIOPH
マステリ
ドンクック
BR PHARM
韓国BMI
BNFソリューション

タイプ別セグメント
粉末
溶液

用途別セグメント
メソセラピー
骨注入・皮膚充填剤
医薬品
化粧品
創傷治癒製品 & その他

地域別生産量
欧州
中国
韓国
その他

地域別消費
北米
米国
カナダ

アジア太平洋
中国
韓国
その他

欧州
イタリア
フランス
その他の地域

主な章立て
第1章:報告書のスコープ、各市場セグメント(地域別、タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな見解を提供しています。
第2章:ポリデオキシリボヌデオチド(PDRN)メーカーの競争環境、価格、生産量、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章:ポリデオキシリボヌデオチド(PDRN)の地域/国別の生産/生産量、金額。今後6年間の各地域の市場規模と発展可能性を定量的に分析しています。
第4章 地域レベルおよび国レベルでのポリデオキシリボヌデオチド(PDRN)の消費。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、将来の発展展望、市場空間、生産量を紹介している。
第5章:様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第6章:読者が異なる川下市場におけるブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの市場規模と発展の可能性をカバーする、アプリケーション別に様々な市場セグメントの分析を提供します。
第7章:主要企業のプロフィールを提供し、製品の生産/生産量、価値、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳しく紹介する。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第10章:レポートの要点と結論。

ページTOPに戻る


目次

1 Polydeoxyribonudeotide (PDRN) Market Overview 1
1.1 Product Definition 1
1.2 Polydeoxyribonudeotide (PDRN) by Type 2
1.2.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Type: 2022 VS 2029 2
1.2.2 Powder 4
1.2.3 Solution 4
1.3 Polydeoxyribonudeotide (PDRN) by Application 4
1.3.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Application: 2022 VS 2029 5
1.3.2 Mesotherapy 6
1.3.3 Bone Injection & Dermal Fillers 7
1.3.4 Pharmaceutical 8
1.3.5 Cosmetic 9
1.3.6 Wound Healing Products & Others 10
1.4 Global Market Growth Prospects 11
1.4.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 11
1.4.2 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts (2018-2029) 12
1.4.3 Global Polydeoxyribonudeotide (PDRN) Market Average Price Estimates and Forecasts (2018-2029) 13
1.5 Assumptions and Limitations 13
2 Market Competition by Manufacturers 16
2.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Manufacturers (2018-2023) 16
2.2 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Manufacturers (2018-2023) 18
2.3 Global Key Players of Polydeoxyribonudeotide (PDRN), Industry Ranking, 2021 VS 2022 19
2.4 Global Polydeoxyribonudeotide (PDRN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
2.5 Global Polydeoxyribonudeotide (PDRN) Average Price by Manufacturers (2018-2023) 21
2.6 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Manufacturing Base Distribution and Headquarters 21
2.7 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Product Offered and Raw Material Status 22
2.8 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Establish Date 23
2.9 Polydeoxyribonudeotide (PDRN) Market Competitive Situation and Trends 23
2.9.1 Polydeoxyribonudeotide (PDRN) Market Concentration Rate 23
2.9.2 Global 3 and 5 Largest Polydeoxyribonudeotide (PDRN) Players Market Share by Revenue 24
2.10 Mergers & Acquisitions, Expansion 25
3 Polydeoxyribonudeotide (PDRN) Production by Region 27
3.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 27
3.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Region (2018-2029) 29
3.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Region (2018-2023) 29
3.2.2 Global Forecasted Production Value of Polydeoxyribonudeotide (PDRN) by Region (2024-2029) 29
3.3 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 30
3.4 Global Polydeoxyribonudeotide (PDRN) Production by Region (2018-2029) 32
3.4.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Region (2018-2023) 32
3.4.2 Global Forecasted Production of Polydeoxyribonudeotide (PDRN) by Region (2024-2029) 32
3.5 Global Polydeoxyribonudeotide (PDRN) Market Price Analysis by Region (2018-2023) 33
3.6 Global Polydeoxyribonudeotide (PDRN) Production and Value, Year-over-Year Growth 34
3.6.1 Europe Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 34
3.6.2 China Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 34
3.6.3 South Korea Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 35
4 Polydeoxyribonudeotide (PDRN) Consumption by Region 37
4.1 Global Polydeoxyribonudeotide (PDRN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 37
4.2 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 39
4.2.1 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 39
4.2.2 Global Polydeoxyribonudeotide (PDRN) Forecasted Consumption by Region (2024-2029) 39
4.3 North America 40
4.3.1 North America Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 41
4.3.2 North America Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029) 41
4.3.3 U.S. 42
4.3.4 Canada 43
4.4 Europe 44
4.4.1 Europe Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 44
4.4.2 Europe Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029) 45
4.4.3 Italy 46
4.4.4 France 47
4.5 Asia Pacific 48
4.5.1 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 48
4.5.2 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 49
4.5.3 China 50
4.5.4 South Korea 51
5 Segment by Type 52
5.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2029) 52
5.1.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2023) 52
5.1.2 Global Polydeoxyribonudeotide (PDRN) Production by Type (2024-2029) 52
5.1.3 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Type (2018-2029) 52
5.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2029) 53
5.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2023) 53
5.2.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2024-2029) 54
5.2.3 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Type (2018-2029) 54
5.3 Global Polydeoxyribonudeotide (PDRN) Price by Type (2018-2029) 55
6 Segment by Application 57
6.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2029) 57
6.1.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2023) 57
6.1.2 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2024-2029) 57
6.1.3 Global Polydeoxyribonudeotide (PDRN) Sales Market Share by Application (2018-2029) 57
6.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2029) 59
6.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2023) 59
6.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2024-2029) 59
6.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value Market Share by Application (2018-2029) 60
6.3 Global Polydeoxyribonudeotide (PDRN) Price by Application (2018-2029) 61
7 Key Companies Profiled 63
7.1 HTL Biotechnology 63
7.1.1 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Company Information 63
7.1.2 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Portfolio 63
7.1.3 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 64
7.1.4 HTL Biotechnology Main Business and Markets Served 65
7.1.5 HTL Biotechnology Recent Developments/Updates 66
7.2 ReaLi Tide Biological 66
7.2.1 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Company Information 66
7.2.2 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Portfolio 67
7.2.3 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 67
7.2.4 ReaLi Tide Biological Main Business and Markets Served 68
7.3 PharmaResearch Co., Ltd. 69
7.3.1 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Company Information 69
7.3.2 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Portfolio 70
7.3.3 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 71
7.3.4 PharmaResearch Co., Ltd. Main Business and Markets Served 71
7.3.5 PharmaResearch Co., Ltd. Recent Developments/Updates 72
7.4 Humedix 72
7.4.1 Humedix Polydeoxyribonudeotide (PDRN) Company Information 72
7.4.2 Humedix Polydeoxyribonudeotide (PDRN) Product Portfolio 73
7.4.3 Humedix Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 74
7.4.4 Humedix Main Business and Markets Served 74
7.5 Ruijiming Biological 75
7.5.1 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Company Information 75
7.5.2 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Portfolio 75
7.5.3 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 77
7.5.4 Ruijiming Biological Main Business and Markets Served 77
7.5.5 Ruijiming Biological Recent Developments/Updates 78
7.6 HENGYU BIOPH 79
7.6.1 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Company Information 79
7.6.2 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Portfolio 79
7.6.3 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 80
7.6.4 HENGYU BIOPH Main Business and Markets Served 80
7.7 Mastelli 82
7.7.1 Mastelli Polydeoxyribonudeotide (PDRN) Company Information 82
7.7.2 Mastelli Polydeoxyribonudeotide (PDRN) Product Portfolio 82
7.7.3 Mastelli Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 83
7.7.4 Mastelli Main Business and Markets Served 83
7.8 Dongkook 85
7.8.1 Dongkook Polydeoxyribonudeotide (PDRN) Company Information 85
7.8.2 Dongkook Polydeoxyribonudeotide (PDRN) Product Portfolio 85
7.8.3 Dongkook Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 86
7.8.4 Dongkook Main Business and Markets Served 86
7.8.5 Dongkook Recent Developments/Updates 87
7.9 BR PHARM 87
7.9.1 BR PHARM Polydeoxyribonudeotide (PDRN) Company Information 87
7.9.2 BR PHARM Polydeoxyribonudeotide (PDRN) Product Portfolio 88
7.9.3 BR PHARM Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 89
7.9.4 BR PHARM Main Business and Markets Served 90
7.10 BMI KOREA 90
7.10.1 BMI KOREA Polydeoxyribonudeotide (PDRN) Company Information 90
7.10.2 BMI KOREA Polydeoxyribonudeotide (PDRN) Product Portfolio 91
7.10.3 BMI KOREA Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 92
7.10.4 BMI KOREA Main Business and Markets Served 92
7.10.5 BMI KOREA Recent Developments/Updates 92
7.11 BNF Solution 93
7.11.1 BNF Solution Polydeoxyribonudeotide (PDRN) Company Information 93
7.11.2 BNF Solution Polydeoxyribonudeotide (PDRN) Product Portfolio 93
7.11.3 BNF Solution Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 95
7.11.4 BNF Solution Main Business and Markets Served 96
7.11.5 BNF Solution Recent Developments/Updates 96
8 Industry Chain and Sales Channels Analysis 98
8.1 Polydeoxyribonudeotide (PDRN) Industry Chain Analysis 98
8.2 Polydeoxyribonudeotide (PDRN) Key Raw Materials 98
8.2.1 Key Raw Materials 98
8.2.2 Raw Materials Key Suppliers 98
8.3 Polydeoxyribonudeotide (PDRN) Production Mode & Process 99
8.4 Polydeoxyribonudeotide (PDRN) Sales and Marketing 100
8.4.1 Polydeoxyribonudeotide (PDRN) Sales Channels 100
8.4.2 Polydeoxyribonudeotide (PDRN) Distributors 100
8.5 Polydeoxyribonudeotide (PDRN) Customers 101
9 Polydeoxyribonudeotide (PDRN) Market Dynamics 103
9.1 Polydeoxyribonudeotide (PDRN) Industry Trends 103
9.2 Polydeoxyribonudeotide (PDRN) Market Drivers 103
9.3 Polydeoxyribonudeotide (PDRN) Market Challenges 104
9.4 Polydeoxyribonudeotide (PDRN) Market Restraints 105
10 Research Findings and Conclusion 106
11 Methodology and Data Source 108
11.1 Methodology/Research Approach 108
11.1.1 Research Programs/Design 108
11.1.2 Market Size Estimation 109
11.1.3 Market Breakdown and Data Triangulation 110
11.2 Data Source 111
11.2.1 Secondary Sources 111
11.2.2 Primary Sources 112
11.3 Author List 113
11.4 Disclaimer 115

 

ページTOPに戻る


 

Summary

The global Polydeoxyribonudeotide (PDRN) market was valued at US$ 25.82 million in 2022 and is anticipated to reach US$ 286.32 million by 2029, witnessing a CAGR of 43.39% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 8.08 million in 2023 to reach $ 64.19 million by 2029, at a CAGR of 41.26% during the forecast period of 2023 through 2029.
China market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 13.43 million in 2023 to reach $ 132.32 million by 2029, at a CAGR of 46.42% during the forecast period of 2023 through 2029.
South Korea market for Polydeoxyribonudeotide (PDRN) is estimated to increase from $ 10.93 million in 2023 to reach $ 84.26 million by 2029, at a CAGR of 40.55% during the forecast period of 2023 through 2029.
The major global manufacturers of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology, Ruijiming Biological, PharmaResearch Co., Ltd., Humedix, ReaLi Tide Biological, HENGYU BIOPH, Mastelli, Dongkook, BR PHARM, BMI KOREA, BNF Solution, etc. In 2022, the world's top three vendors accounted for approximately 55.53% of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Polydeoxyribonudeotide (PDRN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polydeoxyribonudeotide (PDRN).

The Polydeoxyribonudeotide (PDRN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Polydeoxyribonudeotide (PDRN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polydeoxyribonudeotide (PDRN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company
HTL Biotechnology
Ruijiming Biological
PharmaResearch Co., Ltd.
Humedix
ReaLi Tide Biological
HENGYU BIOPH
Mastelli
Dongkook
BR PHARM
BMI KOREA
BNF Solution

Segment by Type
Powder
Solution

Segment by Application
Mesotherapy
Bone Injection & Dermal Fillers
Pharmaceutical
Cosmetic
Wound Healing Products & Others

Production by Region
Europe
China
South Korea
Others

Consumption by Region
North America
U.S.
Canada

Asia-Pacific
China
South Korea
Others

Europe
Italy
France
Rest of Europe

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polydeoxyribonudeotide (PDRN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Polydeoxyribonudeotide (PDRN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Polydeoxyribonudeotide (PDRN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Polydeoxyribonudeotide (PDRN) Market Overview 1
1.1 Product Definition 1
1.2 Polydeoxyribonudeotide (PDRN) by Type 2
1.2.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Type: 2022 VS 2029 2
1.2.2 Powder 4
1.2.3 Solution 4
1.3 Polydeoxyribonudeotide (PDRN) by Application 4
1.3.1 Global Polydeoxyribonudeotide (PDRN) Market Value Growth Rate Analysis by Application: 2022 VS 2029 5
1.3.2 Mesotherapy 6
1.3.3 Bone Injection & Dermal Fillers 7
1.3.4 Pharmaceutical 8
1.3.5 Cosmetic 9
1.3.6 Wound Healing Products & Others 10
1.4 Global Market Growth Prospects 11
1.4.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 11
1.4.2 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts (2018-2029) 12
1.4.3 Global Polydeoxyribonudeotide (PDRN) Market Average Price Estimates and Forecasts (2018-2029) 13
1.5 Assumptions and Limitations 13
2 Market Competition by Manufacturers 16
2.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Manufacturers (2018-2023) 16
2.2 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Manufacturers (2018-2023) 18
2.3 Global Key Players of Polydeoxyribonudeotide (PDRN), Industry Ranking, 2021 VS 2022 19
2.4 Global Polydeoxyribonudeotide (PDRN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
2.5 Global Polydeoxyribonudeotide (PDRN) Average Price by Manufacturers (2018-2023) 21
2.6 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Manufacturing Base Distribution and Headquarters 21
2.7 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Product Offered and Raw Material Status 22
2.8 Global Key Manufacturers of Polydeoxyribonudeotide (PDRN), Establish Date 23
2.9 Polydeoxyribonudeotide (PDRN) Market Competitive Situation and Trends 23
2.9.1 Polydeoxyribonudeotide (PDRN) Market Concentration Rate 23
2.9.2 Global 3 and 5 Largest Polydeoxyribonudeotide (PDRN) Players Market Share by Revenue 24
2.10 Mergers & Acquisitions, Expansion 25
3 Polydeoxyribonudeotide (PDRN) Production by Region 27
3.1 Global Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 27
3.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Region (2018-2029) 29
3.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Region (2018-2023) 29
3.2.2 Global Forecasted Production Value of Polydeoxyribonudeotide (PDRN) by Region (2024-2029) 29
3.3 Global Polydeoxyribonudeotide (PDRN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 30
3.4 Global Polydeoxyribonudeotide (PDRN) Production by Region (2018-2029) 32
3.4.1 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Region (2018-2023) 32
3.4.2 Global Forecasted Production of Polydeoxyribonudeotide (PDRN) by Region (2024-2029) 32
3.5 Global Polydeoxyribonudeotide (PDRN) Market Price Analysis by Region (2018-2023) 33
3.6 Global Polydeoxyribonudeotide (PDRN) Production and Value, Year-over-Year Growth 34
3.6.1 Europe Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 34
3.6.2 China Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 34
3.6.3 South Korea Polydeoxyribonudeotide (PDRN) Production Value Estimates and Forecasts (2018-2029) 35
4 Polydeoxyribonudeotide (PDRN) Consumption by Region 37
4.1 Global Polydeoxyribonudeotide (PDRN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029 37
4.2 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 39
4.2.1 Global Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 39
4.2.2 Global Polydeoxyribonudeotide (PDRN) Forecasted Consumption by Region (2024-2029) 39
4.3 North America 40
4.3.1 North America Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 41
4.3.2 North America Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029) 41
4.3.3 U.S. 42
4.3.4 Canada 43
4.4 Europe 44
4.4.1 Europe Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 44
4.4.2 Europe Polydeoxyribonudeotide (PDRN) Consumption by Country (2018-2029) 45
4.4.3 Italy 46
4.4.4 France 47
4.5 Asia Pacific 48
4.5.1 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 48
4.5.2 Asia Pacific Polydeoxyribonudeotide (PDRN) Consumption by Region (2018-2029) 49
4.5.3 China 50
4.5.4 South Korea 51
5 Segment by Type 52
5.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2029) 52
5.1.1 Global Polydeoxyribonudeotide (PDRN) Production by Type (2018-2023) 52
5.1.2 Global Polydeoxyribonudeotide (PDRN) Production by Type (2024-2029) 52
5.1.3 Global Polydeoxyribonudeotide (PDRN) Production Market Share by Type (2018-2029) 52
5.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2029) 53
5.2.1 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2018-2023) 53
5.2.2 Global Polydeoxyribonudeotide (PDRN) Production Value by Type (2024-2029) 54
5.2.3 Global Polydeoxyribonudeotide (PDRN) Production Value Market Share by Type (2018-2029) 54
5.3 Global Polydeoxyribonudeotide (PDRN) Price by Type (2018-2029) 55
6 Segment by Application 57
6.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2029) 57
6.1.1 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2018-2023) 57
6.1.2 Global Polydeoxyribonudeotide (PDRN) Sales by Application (2024-2029) 57
6.1.3 Global Polydeoxyribonudeotide (PDRN) Sales Market Share by Application (2018-2029) 57
6.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2029) 59
6.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2018-2023) 59
6.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2024-2029) 59
6.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value Market Share by Application (2018-2029) 60
6.3 Global Polydeoxyribonudeotide (PDRN) Price by Application (2018-2029) 61
7 Key Companies Profiled 63
7.1 HTL Biotechnology 63
7.1.1 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Company Information 63
7.1.2 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Portfolio 63
7.1.3 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 64
7.1.4 HTL Biotechnology Main Business and Markets Served 65
7.1.5 HTL Biotechnology Recent Developments/Updates 66
7.2 ReaLi Tide Biological 66
7.2.1 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Company Information 66
7.2.2 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Portfolio 67
7.2.3 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 67
7.2.4 ReaLi Tide Biological Main Business and Markets Served 68
7.3 PharmaResearch Co., Ltd. 69
7.3.1 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Company Information 69
7.3.2 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Portfolio 70
7.3.3 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 71
7.3.4 PharmaResearch Co., Ltd. Main Business and Markets Served 71
7.3.5 PharmaResearch Co., Ltd. Recent Developments/Updates 72
7.4 Humedix 72
7.4.1 Humedix Polydeoxyribonudeotide (PDRN) Company Information 72
7.4.2 Humedix Polydeoxyribonudeotide (PDRN) Product Portfolio 73
7.4.3 Humedix Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 74
7.4.4 Humedix Main Business and Markets Served 74
7.5 Ruijiming Biological 75
7.5.1 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Company Information 75
7.5.2 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Portfolio 75
7.5.3 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 77
7.5.4 Ruijiming Biological Main Business and Markets Served 77
7.5.5 Ruijiming Biological Recent Developments/Updates 78
7.6 HENGYU BIOPH 79
7.6.1 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Company Information 79
7.6.2 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Portfolio 79
7.6.3 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 80
7.6.4 HENGYU BIOPH Main Business and Markets Served 80
7.7 Mastelli 82
7.7.1 Mastelli Polydeoxyribonudeotide (PDRN) Company Information 82
7.7.2 Mastelli Polydeoxyribonudeotide (PDRN) Product Portfolio 82
7.7.3 Mastelli Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 83
7.7.4 Mastelli Main Business and Markets Served 83
7.8 Dongkook 85
7.8.1 Dongkook Polydeoxyribonudeotide (PDRN) Company Information 85
7.8.2 Dongkook Polydeoxyribonudeotide (PDRN) Product Portfolio 85
7.8.3 Dongkook Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 86
7.8.4 Dongkook Main Business and Markets Served 86
7.8.5 Dongkook Recent Developments/Updates 87
7.9 BR PHARM 87
7.9.1 BR PHARM Polydeoxyribonudeotide (PDRN) Company Information 87
7.9.2 BR PHARM Polydeoxyribonudeotide (PDRN) Product Portfolio 88
7.9.3 BR PHARM Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 89
7.9.4 BR PHARM Main Business and Markets Served 90
7.10 BMI KOREA 90
7.10.1 BMI KOREA Polydeoxyribonudeotide (PDRN) Company Information 90
7.10.2 BMI KOREA Polydeoxyribonudeotide (PDRN) Product Portfolio 91
7.10.3 BMI KOREA Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 92
7.10.4 BMI KOREA Main Business and Markets Served 92
7.10.5 BMI KOREA Recent Developments/Updates 92
7.11 BNF Solution 93
7.11.1 BNF Solution Polydeoxyribonudeotide (PDRN) Company Information 93
7.11.2 BNF Solution Polydeoxyribonudeotide (PDRN) Product Portfolio 93
7.11.3 BNF Solution Polydeoxyribonudeotide (PDRN) Production, Value and Price (2018-2023) 95
7.11.4 BNF Solution Main Business and Markets Served 96
7.11.5 BNF Solution Recent Developments/Updates 96
8 Industry Chain and Sales Channels Analysis 98
8.1 Polydeoxyribonudeotide (PDRN) Industry Chain Analysis 98
8.2 Polydeoxyribonudeotide (PDRN) Key Raw Materials 98
8.2.1 Key Raw Materials 98
8.2.2 Raw Materials Key Suppliers 98
8.3 Polydeoxyribonudeotide (PDRN) Production Mode & Process 99
8.4 Polydeoxyribonudeotide (PDRN) Sales and Marketing 100
8.4.1 Polydeoxyribonudeotide (PDRN) Sales Channels 100
8.4.2 Polydeoxyribonudeotide (PDRN) Distributors 100
8.5 Polydeoxyribonudeotide (PDRN) Customers 101
9 Polydeoxyribonudeotide (PDRN) Market Dynamics 103
9.1 Polydeoxyribonudeotide (PDRN) Industry Trends 103
9.2 Polydeoxyribonudeotide (PDRN) Market Drivers 103
9.3 Polydeoxyribonudeotide (PDRN) Market Challenges 104
9.4 Polydeoxyribonudeotide (PDRN) Market Restraints 105
10 Research Findings and Conclusion 106
11 Methodology and Data Source 108
11.1 Methodology/Research Approach 108
11.1.1 Research Programs/Design 108
11.1.2 Market Size Estimation 109
11.1.3 Market Breakdown and Data Triangulation 110
11.2 Data Source 111
11.2.1 Secondary Sources 111
11.2.2 Primary Sources 112
11.3 Author List 113
11.4 Disclaimer 115

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る